药房作为流感疫苗接种点的流行病学与经济影响模拟
研究利用美国基于主体的模型和临床经济学结局模型,模拟2017年不同流感疫情下在传统接种点之外增加药房接种的影响。结果表明,增加药房接种可提高接种覆盖率,减少有症状流感病例和死亡,并产生成本节约。
核心结论
- 药房应被视为疫情疫苗分发点,在疫苗可用时与传统场所一同使用。
研究设计与样本
- 研究利用美国基于主体的模型和临床与经济学结局模型,模拟2017年不同流感疫情及在传统地点(医院、诊所/医生办公室、急诊护理中心)之外增加药房接种的影响。
临床怎么用
- 在流感疫情中,可考虑将药房作为传统接种点之外的疫苗分发点,以增加接种覆盖率和减少疾病负担。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: During an influenza epidemic, where early vaccination is crucial, pharmacies may be a resource to increase vaccine distribution reach and capacity. METHODS: We utilized an agent-based model of the US and a clinical and economics outcomes model to simulate the impact of different influenza epidemics and the impact of utilizing pharmacies in addition to traditional (hospitals, clinic/physician offices, and urgent care centers) locations for vaccination for the year 2017. RESULTS: For an epidemic with a reproductive rate (R0) of 1.30, adding pharmacies with typical business hours averted 11.9 million symptomatic influenza cases, 23,577 to 94,307 deaths, $1.0 billion in direct (vaccine administration and healthcare) costs, $4.2-44.4 billion in productivity losses, and $5.2-45.3 billion in overall costs (varying with mortality rate). Increasing the epidemic severity (R0 of 1.63), averted 16.0 million symptomatic influenza cases, 35,407 to 141,625 deaths, $1.9 billion in direct costs, $6.0-65.5 billion in productivity losses, and $7.8-67.3 billion in overall costs (varying with mortality rate). Extending pharmacy hours averted up to 16.5 million symptomatic influenza cases, 145,278 deaths, $1.9 billion direct costs, $4.1 billion in productivity loss, and $69.5 billion in overall costs. Adding pharmacies resulted in a cost-benefit of $4.1 to $11.5 billion, varying epidemic severity, mortality rate, pharmacy hours, location vaccination rate, and delay in the availability of the vaccine. CONCLUSIONS: Administering vaccines through pharmacies in addition to traditional locations in the event of an epidemic can increase vaccination coverage, mitigating up to 23.7 million symptomatic influenza cases, providing cost-savings up to $2.8 billion to third-party payers and $99.8 billion to society. Pharmacies should be considered as points of dispensing epidemic vaccines in addition to traditional settings as soon as vaccines become available.
引用
- Bartsch SM, Taitel MS, DePasse JV, et al. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic. Vaccine. 2018. PMID: 30340884. doi:10.1016/j.vaccine.2018.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。